Vincristine sulfate - Sökresultat

Malaysia - engelska - NPRA (National Pharmaceutical Regulatory Agency, Bahagian Regulatori Farmasi Negara)

dbl® vincristine sulfate injection 2mg2ml

hospira malaysia sdn bhd - vincristine sulphate -

Australien - engelska - Department of Health (Therapeutic Goods Administration)

hospira vincristine solution injection, 2 mg/2 ml vial

hospira australia pty ltd - vincristine sulfate, quantity: 1 mg/ml - injection - excipient ingredients: mannitol; water for injections; sodium hydroxide; sulfuric acid - this medicine is indicated in certain diseases of the blood and in certain tumours.

USA - engelska - NLM (National Library of Medicine)

vinblastine sulfate- vinblastine sulfate injection

fresenius kabi usa, llc - vinblastine sulfate (unii: n00w22yo2b) (vinblastine - unii:5v9klz54cy) - vinblastine sulfate 1 mg in 1 ml - vinblastine sulfate injection is indicated in the palliative treatment of the following: i. frequently responsive malignancies - generalized hodgkin’s disease (stages iii and iv, ann arbor modification of rye staging system) - lymphocytic lymphoma (nodular and diffuse, poorly and well differentiated) - histiocytic lymphoma - mycosis fungoides (advanced stages) - advanced carcinoma of the testis - kaposi’s sarcoma - letterer-siwe disease (histiocytosis x) ii. less frequently responsive malignancies - choriocarcinoma resistant to other chemotherapeutic agents - carcinoma of the breast, unresponsive to appropriate endocrine surgery and hormonal therapy current principles of chemotherapy for many types of cancer include the concurrent administration of several antineoplastic agents. for enhanced therapeutic effect without additive toxicity, agents with different dose-limiting clinical toxicities and different mechanisms of action are generally selected. therefore, although vinblastine